Tolevamer

N/A

Report date: 2022/07/05 20:38:36
NME

Base Information

Drug NameTolevamer
Drug Alias NameTolevamer sodiumTolevamer potassium sodiumToxin binder - Sanofi GenzymeTolevamer toxin binderExodif +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial toxin inhibitors
TargetsBacterial toxin
Therapy Area/IndicationsDiarrheaEnterocolitis, PseudomembranousClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[17] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenzyme Corp
Active IndicationsN/A
Inactive IndicationsDiarrheaEnterocolitis, PseudomembranousClostridium Infections

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG